5-FLUOROURACIL/LEUCOVORIN/INTERFERON ALPHA-2A IN PATIENTS WITH ADVANCED COLORECTAL-CANCER

被引：0
|
作者：
VERMEULEN, PB
DIRIX, LY
PELGRIMS, G
VANOOSTEROM, AT
机构：
来源：
CANCER | 1995年 / 76卷 / 03期
关键词：
D O I：
10.1002/1097-0142(19950801)76:3<528::AID-CNCR2820760327>3.0.CO;2-W
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：528 / 529
页数：2
相关论文
共 50 条
  • [21] A COMPARATIVE-STUDY WITH 2 ADMINISTRATION SCHEDULES OF LEUCOVORIN AND 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER
    TSAVARIS, N
    FOUTZILAS, G
    MARKANTONAKIS, P
    MYLONAKIS, N
    BACOYANNIS, C
    ZISIADIS, A
    BASDANIS, G
    KARVOUNIS, N
    SOBOLOS, K
    KOSMIDIS, P
    JOURNAL OF CHEMOTHERAPY, 1995, 7 (01) : 71 - 77
  • [22] PHARMACOKINETICS OF 5-FLUOROURACIL IN COLORECTAL-CANCER PATIENTS RECEIVING INTERFERON
    PITTMAN, K
    PERREN, T
    WARD, U
    PRIMROSE, J
    SLEVIN, M
    PATEL, N
    SELBY, P
    ANNALS OF ONCOLOGY, 1993, 4 (06) : 515 - 516
  • [23] ALPHA-INTERFERON IN COMBINATION WITH 5-FLUOROURACIL AND LEUCOVORIN IN METASTATIC COLORECTAL-CANCER - A PHASE-I STUDY
    PUNT, CJA
    DEMULDER, PHM
    BURGHOUTS, JTM
    WAGENER, DJT
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (04) : 326 - 328
  • [24] PROTRACTED VENOUS INFUSION 5-FLUOROURACIL AND INTERFERON-ALPHA IN ADVANCED AND REFRACTORY COLORECTAL-CANCER
    FINDLAY, M
    HILL, A
    CUNNINGHAM, D
    NORMAN, A
    NICOLSON, M
    FORD, H
    HUSBAND, J
    EVANS, C
    CARTER, R
    ANNALS OF ONCOLOGY, 1994, 5 (03) : 239 - 243
  • [25] EFFECT OF CISPLATIN IN ADVANCED COLORECTAL-CANCER RESISTANT TO 5-FLUOROURACIL PLUS (S)-LEUCOVORIN
    CASSANO, A
    POZZO, C
    CORSI, CD
    FONTANA, T
    NOVIELLO, MR
    ASTONE, A
    BARONE, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (08) : 474 - 477
  • [26] THE COMBINATION OF 5-FLUOROURACIL WITH MISONIDAZOLE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER
    SPOONER, D
    BUGDEN, RD
    PECKHAM, MJ
    WIST, EA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4): : 387 - 389
  • [27] Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer
    Goey, SH
    Gratama, JW
    Primrose, JN
    Ward, U
    Mertelsmann, RH
    Osterwalder, B
    Verweij, J
    Stoter, G
    BRITISH JOURNAL OF CANCER, 1996, 74 (12) : 2018 - 2023
  • [28] IMMUNOCHEMOTHERAPY OF ADVANCED COLORECTAL-CANCER WITH ALPHA-INTERFERON AND 5-FLUOROURACIL .1. TOXICOLOGICAL STUDIES
    DEVECCHIS, L
    NUNZIATA, C
    RICCI, F
    CUCCHIARA, G
    PICCONI, A
    BONMASSAR, G
    CAPRINO, ML
    BONMASSAR, E
    JOURNAL OF CHEMOTHERAPY, 1989, 1 (02) : 128 - 135
  • [29] TREATMENT OF ADVANCED COLORECTAL-CANCER WITH 5-FLUOROURACIL AND INTERFERON-ALPHA - AN OVERVIEW OF CLINICAL-TRIALS
    RADERER, M
    SCHEITHAUER, W
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (06) : 1002 - 1008
  • [30] A PHASE-II STUDY OF ADVANCED COLORECTAL-CANCER PATIENTS TREATED WITH COMBINATION 5-FLUOROURACIL PLUS LEUCOVORIN AND SUBCUTANEOUS INTERLEUKIN-2 PLUS ALPHA-INTERFERON
    RIDOLFI, R
    RICCOBON, A
    FEDRIGA, R
    PEZZI, L
    SANTONI, A
    MALTONI, R
    FLAMINI, E
    MILANDRI, C
    VELOTTI, F
    AMADORI, D
    JOURNAL OF CHEMOTHERAPY, 1994, 6 (04) : 265 - 271
12345